References
- Saaddine JB Cadwell B Gregg EW et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann. Intern. Med.144 (7), 465–474 (2006).
- Hoffman A Ziv E . Pharmacokinetic considerations of new insulin formulations and routes of administration. Clin. Pharmacokinet.33 (4), 285–301 (1997).
- Owens DR . New horizons – alternative routes for insulin therapy. Nat. Rev. Drug Discov.1 (7), 529–540 (2002).
- Arbit E Kidron M . Oral insulin delivery in a physiologic context: review. J. Diabetes Sci. Technol.11 (4), 825–832 (2017).
- Carino GP Mathiowitz E . Oral insulin delivery1Abbreviations: GI, gastrointestinal; IDDM, insulin-dependent diabetes mellitus; IU, international units; NIDDM, non-insulin-dependent diabetes mellitus; PIN, phase inversion nanoencapsulation; ZOT, zona occludens toxin.1. Adv. Drug Del. Rev.35 (2), 249–257 (1999).
- Heinemann L . New ways of insulin delivery. Int. J. Clin. Pract. Suppl. (170), 31–46 (2011).
- Fonte P Araujo F Reis S Sarmento B . Oral insulin delivery: how far are we?J. Diabetes Sci. Technol.7 (2), 520–531 (2013).
- Zijlstra E Heinemann L Plum-Morschel L . Oral insulin reloaded: a structured approach. J. Diabetes Sci. Technol.8 (3), 458–465 (2014).
- Zaykov AN Mayer JP Dimarchi RD . Pursuit of a perfect insulin. Nat. Rev. Drug Discov.15 (6), 425–439 (2016).
- Wong CY Martinez J Dass CR . Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J. Pharm. Pharmacol.68 (9), 1093–1108 (2016).
- Samson SL Chan L . Gene therapy for diabetes: reinventing the islet. Trends Endocrinol. Metab.17 (3), 92–100 (2006).
- Alam T Wai P Held D Vakili ST Forsberg E Sollinger H . Correction of diabetic hyperglycemia and amelioration of metabolic anomalies by minicircle DNA mediated glucose-dependent hepatic insulin production. PLoS ONE8 (6), e67515 (2013).
- Jariyapong P Xing L Van Houten NE et al. Chimeric hepatitis E virus-like particle as a carrier for oral-delivery. Vaccine31 (2), 417–424 (2013).
- Chen CC Xing L Stark M et al. Chemically activatable viral capsid functionalized for cancer targeting. Nanomedicine (Lond.)11 (4), 377–390 (2016).
- Holland CR Xing L Chieh CC Christine SM : WO/2015/179321 (2015).
- Takamura S Niikura M Li TC et al. DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. Gene Ther.11 (7), 628–635 (2004).
- Google Patents : US8906863 (2014).
- Stark MC Baikoghli MA Lahtinen T et al. Structural characterization of site-modified nanocapsid with monodispersed gold clusters. Sci. Rep.7 (1), 17048 (2017).
- Li W Chen X . Gold nanoparticles for photoacoustic imaging. Nanomedicine10 (2), 299–320 (2015).
- Niu L Xu YC Xie HY Dai Z Tang HQ . Expression of human insulin gene wrapped with chitosan nanoparticles in NIH3T3 cells and diabetic rats. Acta Pharmacol. Sin.29 (11), 1342–1349 (2008).
- Mukhopadhyay P Sarkar K Chakraborty M Bhattacharya S Mishra R Kundu PP . Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model. Mater. Sci. Eng. C Mater. Biol. Appl.33 (1), 376–382 (2013).